CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake ((123/131)I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors

BACKGROUND: Neuroblastoma (NB) and pheochromocytoma/paraganglioma (PHEO/PGL) are neuroendocrine tumors. Imaging of these neoplasms is performed by scintigraphy after injection of radiolabeled meta-iodobenzylguanidine (mIBG), a norepinephrine analog taken up by tumoral cells through monoamine transpo...

Descripción completa

Detalles Bibliográficos
Autores principales: Grand-Guillaume, Joana, Mansi, Rosalba, Gaonkar, Raghuvir H., Zanger, Sandra, Fani, Melpomeni, Eugster, Philippe J., Beck Popovic, Maja, Grouzmann, Eric, Abid, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485979/
https://www.ncbi.nlm.nih.gov/pubmed/37679770
http://dx.doi.org/10.1186/s12967-023-04466-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485979/
https://www.ncbi.nlm.nih.gov/pubmed/37679770
http://dx.doi.org/10.1186/s12967-023-04466-z

Ejemplares similares